TITLE

Kaleidoscope

AUTHOR(S)
Ely, E. Wesley
PUB. DATE
January 2015
SOURCE
Annals of Internal Medicine;1/20/2015, Vol. 162 Issue 2, p152
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A personal narrative is presented which explores the author's experience of treating various patients with serious diseases such as gram-negative sepsis complicating peritoneal dialysis, pulmonary fibrosis, and nonalcoholic steatohepatitis.
ACCESSION #
100468880

 

Related Articles

  • Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Murphy, Sean W.; Foley, Robert N.; Barrett, Brendan J.; Kent, Gloria M.; Morgan, Janet; Barré, Paul; Campbell, Patricia; Fine, Adrian; Goldstein, Marc B.; Handa, S. Paul; Jindal, Kailash K.; Levin, Adeera; Mandin, Henry; Muirhead, Norman; Richardson, Robert M.A.; Parfrey, Patrick S. // Kidney International;Jun2000, Vol. 57 Issue 6, p2557 

    Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada. Background. Most comparisons of hemodialysis (HD) and peritoneal dialysis (PD) have used mortality as an outcome. Relatively few studies have directly compared the hospitalization rates, an outcome of perhaps...

  • Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. Vychytil, Andreas; Födinger, Manuela; Wölfl, Gabriele; Enzenberger, Brigitte; Auinger, Martin; Prischl, Friedrich; Buxbaum, Martina; Wiesholzer, Martin; Mannhalter, Christine; Hörl, Walter H.; Sunder-Plassmann, Gere // Kidney International;Jun1998, Vol. 53 Issue 6, p1775 

    Major determinants of hyperhomocysteinemia in peritoneal dialysis patients. The mechanisms leading to elevated total homocysteine concentrations in peritoneal dialysis patients are only partially understood. We show that a common polymorphism in the 5,10-methylenetetrahydrofolate reductase...

  • Patients in Assisted Automated Peritoneal Dialysis Develop Strategies for Self-Care. Holch, Kirsten // Nephrology Nursing Journal;Mar/Apr2008, Vol. 35 Issue 2, p176 

    Background: Since 2000, a model for assisted automated peritoneal dialysis (aAPD) for patients in their own home needing chronic dialysis treatment has been developed at Aarhus University Hospital, Skejby, Denmark. The patient group consists of physically or mentally frail elderly who cannot...

  • Re: Effects of Low-glucose Degradation Product Solution on Peritoneal Membrane Characteristics in Peritoneal Dialysis Patients: a 3-year Follow-up Study. Ahmadi, Farrokhlagha // Iranian Journal of Kidney Diseases;Mar2014, Vol. 8 Issue 2, p158 

    A response from the author of the article regarding the effects of low-glucose degradation product solution on peritoneal membrane characteristics in peritoneal dialysis patients in the previous issue is presented.

  • Left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients. Gallieni, Maurizio; Pedone, Meri // Kidney International;Oct2013, Vol. 84 Issue 4, p850 

    A letter to the editor is presented in response to an article related to presence of left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients, published in previous issue.

  • The Authors Reply:. Yamamoto, Kalani T; Kestenbaum, Bryan R // Kidney International;Oct2013, Vol. 84 Issue 4, p850 

    A response from the author of the article related to presence of left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients, published in previous issue, is presented.

  • Catheter removal/antifungal resolves fungal peritonitis in children on PD.  // Kidney;Jan/Feb2001, Vol. 10 Issue 1, p28 

    Presents an abstract of the study 'Fungal Peritonitis in Children Receiving Peritoneal Dialysis: A Report of the NAPRTCS,' by B.A. Warady, M. Bashir and L.A. Donaldson.

  • Atorvastatin: a potent HMG-CoA reductase inhibitor.  // Kidney;Jan/Feb2001, Vol. 10 Issue 1, p43 

    Presents an abstract of the study 'Effects of Atorvastatin on Dyslipidaemia in Uraemic Patients on Peritoneal Dialysis,' by G. Hufnagel, C. Michel, F. Vrtovsnik et al.

  • Pirfenidone.  // Reactions Weekly;May2015, Vol. 1550 Issue 1, p172 

    The article presents a case study of a 67-year-old man who developed headache, nausea, and anorexia following administration of pirfenidone for treatment of restrictive allograft syndrome following lung transplantation, published in the September 2014 issue of the "European Respiratory Journal."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics